COVID-19's hidden toll: fungal infections in transplant patients under the microscope
NCT ID NCT06900114
First seen Mar 20, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This study looked at 60 blood cancer patients who had a stem cell transplant and later developed a serious fungal infection called mucormycosis. Researchers compared cases before COVID-19 (2015-2020) and during the pandemic (2020-2024) to see how the virus, new tests, and treatments changed the infection's impact. The goal is to improve how doctors manage this rare but dangerous infection in transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Conditions
Explore the condition pages connected to this study.